![Chenyu Lin: Important CAR T-cell debate in ALL featuring Ryan Cassaday and Nitin Jain](https://oncodaily.com/pub/uploads/2024/08/Screenshot-2024-08-19-035604-e1724025571983.png)
Collage photo Ryan Cassaday and Nitin Jain
Aug 18, 2024, 20:22
Chenyu Lin: Important CAR T-cell debate in ALL featuring Ryan Cassaday and Nitin Jain
Chenyu Lin, Assistant Professor of Medicine at Duke University School of Medicine, shared on X:
“Important CAR T-cell debate (Brexu-cel vs. Obe-cel in ALL) featuring Ryan Cassaday and Nitin Jain!
- Brexu-cel has long-term outcomes, reliable manufacturing, and ease of use.
- Obe-cel’s unique kinetics grant a favorable toxicity profile with seemingly comparable efficacy.
With shoutouts to the great work coming out of Lori Muffly ROCCA studies.”
Source: Chenyu Lin/X